Most of the human studies we have are case studies, meaning they feature results from one patient: A 2009 case study on one expecting parent using exenatide suggested there was no fetal harm, though she discontinued exenatide use during the first trimester
Proper injection technique is essential for patients using Zepbound (tirzepatide), an FDA-approved medication for chronic weight management
Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), is on track to become the leading cause of liver transplantation in Western countries and a significant factor in hepatocellular carcinoma (HCC), cardiovascular issues, and overall mortality [1, 2]
Identify people who can help during the peak side effect weeks, typically weeks 5 through 10
You know, anytime you lose weight, you feel better
Individual Variation: Effects varied among participants within trials